Picard Medical and SynCardia Highlight Total Artificial Heart on BTV Program Airing on FOX Business News

The segment will showcase the SynCardia Total Artificial Heart, the world's first FDA and Health Canada approved artificial heart.

Mar. 16, 2026 at 2:36pm

Got story updates? Submit your updates here. ›

Picard Medical, Inc., the parent company of SynCardia Systems LLC, announced that the SynCardia Total Artificial Heart will be featured in an upcoming segment on BTV Business Television airing on the FOX Business News. The segment will highlight the company's artificial heart technology designed to replace the pumping function of a failing human heart while patients await transplantation. With over 2,100 implants performed worldwide, the SynCardia Total Artificial Heart remains the most widely used and extensively studied artificial heart technology globally.

Why it matters

As the number of patients in need of mechanical circulatory support continues to grow, raising awareness of advanced heart failure therapies like the SynCardia Total Artificial Heart is increasingly important. The device has supported over 2,100 patients worldwide by replacing the pumping function of a failing heart and providing critical time for patients awaiting transplantation.

The details

The upcoming BTV segment will also highlight Picard Medical's development of a next-generation, fully implantable artificial heart platform designed to improve patient mobility and quality of life by eliminating external pneumatic drivers. The SynCardia Total Artificial Heart is considered a 'total' replacement since it replaces both left and right ventricles and all four heart valves, restoring circulation in patients with severe biventricular heart failure who are at risk of imminent death without mechanical circulatory support.

  • The segment will air on Saturday, March 14 at 5:00 p.m. EST on FOX Business News.

The players

Picard Medical, Inc.

The parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada.

SynCardia Systems LLC

The Tucson, Arizona-based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure.

U.S. FDA

The U.S. Food and Drug Administration, which has approved the SynCardia Total Artificial Heart.

Health Canada

The Canadian federal department responsible for national public health, which has also approved the SynCardia Total Artificial Heart.

Patrick N.J. Schnegelsberg

The Chief Executive Officer of Picard Medical.

Got photos? Submit your photos here. ›

What they’re saying

“We believe raising awareness of advanced heart failure therapies is increasingly important as the number of patients in need of mechanical circulatory support continues to grow.”

— Patrick N.J. Schnegelsberg, Chief Executive Officer of Picard Medical (Press Release)

The takeaway

The SynCardia Total Artificial Heart has proven to be a vital technology for patients with severe biventricular heart failure, providing a lifeline while they await a heart transplant. As Picard Medical continues to innovate and develop the next generation of artificial heart technology, this segment on FOX Business News will help raise awareness and understanding of these critical advancements in heart failure treatment.